Skip to content

Early Warning and Classification Model for Acute Non-traumatic Chest Pain

A Prospective Study of Acute Nontraumatic Chest Pain - Warning and Classification

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06196307
Enrollment
10000
Registered
2024-01-09
Start date
2022-08-30
Completion date
2028-12-30
Last updated
2026-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chest Pain

Brief summary

Acute non-traumatic chest pain is one of the common causes of presentation in emergency patients, but the causes of acute non-traumatic chest pain are complex, the severity of the condition varies greatly, and the specificity of symptoms is not high. Machine learning and intelligent auxiliary models can greatly shorten the time of clinical decision-making, and improve the accuracy of etiological diagnosis in patients with chest pain, reduce the rate of misdiagnosis and missed diagnosis, and provide a clear direction for further treatment.

Detailed description

Prospective observational studies used outpatient and follow-up information to construct an auxiliary early warning model of acute non-traumatic chest pain based on federated learning, and optimized the accuracy of early warning models through retrospective and prospective studies of large cohort data, and established an efficient and stable early warning and classification model for acute non-traumatic chest pain.

Interventions

COMBINATION_PRODUCTClinical evaluation, laboratory and cardiac imaging results, medication, surgery, and any hospitalization

Examination: Electrocardiogram、 imaging examination、 X-ray, CTA, bedside echocardiography. Laboratory test results of patients, including complete blood count, D-dimer, myocardial injury markers, sST2, MPO, and other indicators. History of cardiovascular and pulmonary vascular drug therapy: Antithrombotic therapy (type, measurement) , Anticoagulation therapy (type, metering), Other drug treatments (type, measurement)

Sponsors

Xiao-nan He
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age ≥ 18 years 2. Symptom onset or worsening within 24 hours before presentation, with a chief complaint of acute chest pain meeting the broad definition of chest pain (2021 AHA) 3. Presentation to the emergency department, with a clinical diagnosis consistent with non-traumatic chest pain 4. Signed informed consent

Exclusion criteria

1. traumatic chest pain 2. systemic pain caused by malignant tumors or rheumatic diseases involving the chest 3. Patients were lost to follow-up

Design outcomes

Primary

MeasureTime frameDescription
Adverse events30 days after presenting to the emergency departments(ED)The primary outcome was a composite of adjudicated major adverse cardiovascular and cerebrovascular events (MACCE), which included cardiovascular death, all-cause mortality, nonfatal myocardial infarction, refractory angina, new onset heart failure and stroke.

Countries

China

Contacts

CONTACTXiaonan / He, Professor
hxndoctor@126.com15001108399
CONTACTHaotian / Wu, Bachelor
wuhaotian3702@163.com13966123702

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026